Further to its role as a key mediator of the energy balance “set point”, ghrelin is also implicated in incentive salience and motivation to eat, and consequently has become a therapeutic target for development of therapies for overeating and obesity [41,42]. This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.